Oramed Pharmaceuticals

ORMPNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$197.587 M

$4.75 +1.06%

Close of 22 Sept 2026

Revenue

$2.00M

#3419 by revenue

Earnings

$75.3K

#2444 by earnings

Shares outstanding

41,597,354

Latest filing cover page

P/E ratio

2623.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#267Sol-Gel TechnologiesSLGL$199.6M
#268Veraxa Biotech AG - Post de-SPACVRXA$199.4M
#269Oramed PharmaceuticalsORMP$197.6M
#270Canton StrategicCNTN$195.2M
#271OrganogenesisORGO$190.4M

What if Oramed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$726,824.35

Per share 153,016× higher

Bitcoin $1.74T

$41,869.37

Per share 8,815× higher

Nvidia $5.52T

$132,598.99

Per share 27,916× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Oramed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.